Morris Chang says domestic US chip supply chain is impossible
By David Manners, ElectronicsWeekly (October 27, 2021)
Morris Chang says the idea of building a US-based IC supply chain is impossible even if it spent much more than the $52 billion envisaged by the Chips Act.
“If you want to reestablish a complete semiconductor supply chain in the U.S., you will not find it as a possible task,” said Chang in Taipei last night, “even after you spend hundreds of billions of dollars, you will still find the supply chain to be incomplete, and you will find that it will be very high cost, much higher costs than what you currently have.”
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
|
Related News
- Apple-TSMC-Amkor Pact Bolsters U.S. Chip Supply Chain
- Intel to place US$14 billion orders with TSMC, says report
- US Department of Defense Awards SkyWater a $27M Option to Facilitate American-Made Semiconductors Critical to National Security and Domestic Supply Chains
- GLOBALFOUNDRIES and SkyWater Technology Sign MOU for Technology Development to Strengthen Domestic Supply Assurance for U.S. Government
- Inomize is selected as Supply Chain Manager and to support the development of 3D camera and XR ASIC using TSMC 12nm FFC Technology
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design